A Pharmacokinetic Comparability Study of a Commercial Supply of Eptinezumab
Phase of Trial: Phase I
Latest Information Update: 20 Mar 2018
At a glance
- Drugs Eptinezumab (Primary)
- Indications Migraine
- Focus Pharmacokinetics
- 20 Mar 2018 According to an Alder BioPharmaceuticals media release, this study is anticipated to complete in in the second half of 2018.
- 06 Mar 2018 New trial record
- 26 Feb 2018 According to an Alder BioPharmaceuticals media release, the company expects to initiate this trial in 2H 2018.